TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
TEVA

Teva Pharma Industries Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

39.80$ +2.4% vs. previous close Closing price · As of: Sep 29, 2026

Ownership

Ownership Structure

Who owns Teva Pharma Industries Ltd (TEVA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 93.3% of the shares are freely tradable; institutional investors hold 63.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 63.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.00%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 93.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 2.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 1,166Mio.

Largest Shareholders

Institutions

Institutions TEVA
Name Stake (%) Shares Change (%) Date
BlackRock Inc 5.59 65,136,464 +11.7 03/31/2026
Harel Insurance Invests & Fin Srvcs Ltd 3.94 45,956,714 +2.2 03/31/2026
Phoenix Financial Ltd 3.68 42,933,367 +0.4 06/30/2026
WCM Investment Management 3.50 40,820,600 +191.4 03/31/2026
MENORA MIVTACHIM HOLDINGS LIMITED 3.40 39,626,383 +0.8 03/31/2026
Migdal Insurance & Financial Holdings Ltd 3.34 38,922,212 +2.7 06/30/2026
Clal Insurance Enterprises Holdings Ltd 3.30 38,446,506 +2.8 03/31/2026
FMR Inc 2.84 33,132,795 +14.2 03/31/2026
NORGES BANK 2.77 32,299,753 -8.2 06/30/2026
Exor Investments (UK) LLP 1.73 20,205,943 -27.2 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings TEVA
Person Role Shares Value As of Type
Satchi-Fainaro Ronit Director 111,986 4,457,043 $ Aug 21, 2026 direct
Lippman Evan EVP, Business Development 25,591 1,018,522 $ Aug 17, 2026 direct
Weiss Amir Chief Accounting Officer 13,071 520,226 $ Aug 21, 2026 direct
Savage Brian Interim Chief Legal Officer 8,500 338,300 $ Sep 18, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 18, 2026 Savage Brian Interim Chief Legal Officer Sell 314 38.70 12,153
Sep 18, 2026 Savage Brian Interim Chief Legal Officer Sell 2,525 39.15 98,841
Sep 18, 2026 Savage Brian Interim Chief Legal Officer Sell 4,503 38.69 174,221
Sep 18, 2026 Savage Brian Interim Chief Legal Officer Other 4,503 34.70 156,254
Sep 18, 2026 Mignone Roberto Director Sell 367,600 39.06 14,356,802
Aug 21, 2026 Weiss Amir Chief Accounting Officer Sell 2,500 37.63 94,077
Aug 21, 2026 Weiss Amir Chief Accounting Officer Other 2,500 19.61 49,025
Aug 21, 2026 Weiss Amir Chief Accounting Officer Sell 6,945 37.61 261,224
Aug 21, 2026 Satchi-Fainaro Ronit Director Sell 415 37.25 15,459
Aug 17, 2026 Lippman Evan EVP, Business Development Sell 18,600 36.57 680,291

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?